We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
FUSN | Fusion Pharmaceuticals Inc | 20.77 | 10.13 | 95.21% | 64,022 |
OTRK | Ontrak Inc | 0.3521 | 0.1621 | 85.32% | 2,067,465 |
ZCAR | Zoomcar Holdings Inc | 1.59 | 0.41 | 34.75% | 845,702 |
SUGP | SU Group Holdings Ltd | 3.78 | 0.74 | 24.34% | 1 |
LFLY | Leafly Holdings Inc | 3.00 | 0.58 | 23.97% | 10 |
NCMI | National CineMedia Inc | 5.13 | 0.91 | 21.56% | 16,583 |
SPEC | Spectaire Holdings Inc | 1.25 | 0.21 | 20.19% | 475 |
VERB | Verb Technology Company Inc | 0.432 | 0.072 | 20.00% | 171,454 |
CJET | Chijet Motor Company Inc | 0.6752 | 0.0949 | 16.35% | 4,979 |
WKSP | Worksport Ltd | 0.53 | 0.068 | 14.72% | 1 |
AUGX | Augmedix Inc | 3.82 | 0.49 | 14.71% | 7,666 |
Transaction includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities Fusion shareholders to receive $21.00 per share in cash at closing plus a non-transferrable contingent value right (CVR) of $3.00 per share, representing a total transaction value of approximately $2.4 billion including the CVR HAMILTON, ON and BOSTON, March 19, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today announced the Company has entered into a definitive agreement to be acquired by AstraZeneca. The acquisition marks a major step ...
National CineMedia, Inc. (NASDAQ: NCMI) (“the Company” or “NCM”), the managing member of National CineMedia, LLC (“NCM LLC”), the operator of the largest cinema advertising platform in the U.S., today announced its results for the fourth quarter and full year 2023, ended December 28, 2023.
The financial services revenue reached R$ R$ 2.87 billion in 4Q23, 24.4% higher year over year. The growth was driven by MSMB (micro, small, and medium-sized businesses) clients, whose TPV increased by 20.2% year over year (or 25%, considering the processed volume of PIX P2M). The segment also showed a 22 bps increase in take rate year over year.
Multiple clinical trials across three AI-guided drug candidates are active with first expected data and readouts for LP-184 in the second half of 2024; with additional next-generation drug development programs approaching IND studies.
Rank | Board Name | Posts (24h) |
---|---|---|
ORIONS Money Stocks | 179 | |
BBs Stock Haven | 148 | |
MOMOS BREAKOUT BOARD | 106 | |
4 | Dutchman Stocks | 32 |
5 | Savvy Trades and Investments | 25 |
6 | Da Burbs 2 0 | 22 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 64,041.03 | -3,523.05 | -5.21% | 1.25T | 7,850,899,113 |
ETH | Ethereum | 3,302.93 | -215.59 | -6.13% | 394.49B | 4,264,982,774 |
USDT | Tether USD | 0.99956 | -0.00029 | -0.03% | 97.8B | 352,123,242 |
BNB | Binance Coin | 516.20 | -39.06 | -7.03% | 81.2B | 1,421,898,265 |
SOL | Solana | 181.32 | -14.17 | -7.25% | 79.4B | 4,056,845,447 |
STETH | stETH | 3,295.54 | -219.11 | -6.23% | 32.19B | 11,573,038 |
XRP | Ripple | 0.5893 | -0.0568 | -8.79% | 31.95B | 907,304,543 |
USDC | USD Coin | 0.9999 | 0.00 | 0.00% | 28.07B | 1,156,509,565 |
AVAX | Avalanche | 57.85 | -2.65 | -4.38% | 21.63B | 1,205,840,205 |
ADA | Cardano | 0.6144 | -0.0449 | -6.81% | 21.42B | 236,093,632 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |